Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Olema Oncology (Nasdaq: OLMA), a clinical-stage biopharmaceutical company specializing in targeted therapies for women's cancers, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The event is scheduled for Wednesday, September 4, 2024, at 7:45 a.m. ET at the Marriott Marquis in New York, NY.
The company's management team will engage in a Fireside Chat format discussion. Investors and interested parties can access a live webcast of the chat through the News & Events section of Olema's investor relations website at ir.olema.com. The webcast will remain archived for at least 30 days after the event, providing an opportunity for those unable to attend live to catch up on the discussion.
Olema Oncology (Nasdaq: OLMA), un'azienda biofarmaceutica in fase clinica specializzata in terapie mirate per i tumori femminili, ha annunciato la sua partecipazione al 22° Annual Global Healthcare Conference di Morgan Stanley. L'evento è programmato per mercoledì 4 settembre 2024, alle 7:45 a.m. ET presso il Marriott Marquis di New York, NY.
Il team di gestione dell'azienda parteciperà a una discussione in formato Fireside Chat. Gli investitori e le parti interessate possono accedere a un webcast live della conversazione attraverso la sezione News & Events del sito per le relazioni con gli investitori di Olema all'indirizzo ir.olema.com. Il webcast rimarrà archiviato per almeno 30 giorni dopo l'evento, offrendo un'opportunità a coloro che non possono partecipare dal vivo di recuperare la discussione.
Olema Oncology (Nasdaq: OLMA), una empresa biofarmacéutica en etapa clínica que se especializa en terapias dirigidas para el cáncer en mujeres, ha anunciado su participación en la 22ª Conferencia Anual de Atención Médica Global de Morgan Stanley. El evento está programado para el miércoles 4 de septiembre de 2024, a las 7:45 a.m. ET en el Marriott Marquis de Nueva York, NY.
El equipo de gestión de la empresa participará en una discusión en formato Fireside Chat. Los inversionistas y las partes interesadas pueden acceder a un webcast en vivo de la charla a través de la sección de Noticias y Eventos del sitio de relaciones con inversionistas de Olema en ir.olema.com. El webcast permanecerá archivado durante al menos 30 días después del evento, proporcionando una oportunidad para que quienes no puedan asistir en vivo se pongan al día con la discusión.
올레마 항암학 (Nasdaq: OLMA), 여성 암을 위한 표적 치료를 전문으로 하는 임상 단계의 생명공학 회사가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 4일 수요일 오전 7시 45분(ET)에 뉴욕 마리어트 마퀴스에서 열릴 예정입니다.
회사의 경영진 팀은 파이어사이드 채팅 형식의 토론에 참여합니다. 투자자와 관심 있는 분들은 올레마의 투자자 관계 웹사이트 ir.olema.com의 뉴스 및 이벤트 섹션을 통해 채팅의 라이브 웹캐스트에 접속할 수 있습니다. 웹캐스트는 이벤트 후 최소 30일 동안 아카이브 되어, 실시간으로 참석하지 못한 분들이 토론 내용을 확인할 수 있는 기회를 제공합니다.
Olema Oncology (Nasdaq: OLMA), une société biopharmaceutique en phase clinique spécialisée dans les thérapies ciblées pour les cancers des femmes, a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur les Soins de Santé de Morgan Stanley. L'événement est prévu pour le mercredi 4 septembre 2024, à 7h45 ET au Marriott Marquis à New York, NY.
L'équipe de direction de la société participera à une discussion au format Fireside Chat. Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la discussion via la section News & Events du site des relations avec les investisseurs d'Olema à l'adresse ir.olema.com. Le webcast sera archivé pendant au moins 30 jours après l'événement, offrant ainsi la possibilité à ceux qui ne peuvent pas assister en direct de se mettre à jour sur la discussion.
Olema Oncology (Nasdaq: OLMA), ein biopharmazeutisches Unternehmen in der klinischen Phase, das auf gezielte Therapien für Frauenkrebserkrankungen spezialisiert ist, hat seine Teilnahme an der 22. Jahrestagung für globale Gesundheitsversorgung von Morgan Stanley bekannt gegeben. Die Veranstaltung ist für Mittwoch, den 4. September 2024, um 7:45 Uhr ET im Marriott Marquis in New York, NY geplant.
Das Management-Team des Unternehmens wird an einer Diskussion im Format Fireside Chat teilnehmen. Investoren und Interessierte können über die Rubrik News & Events auf der Investor Relations-Website von Olema unter ir.olema.com auf einen Live-Webcast des Chats zugreifen. Der Webcast wird mindestens 30 Tage nach der Veranstaltung archiviert bleiben, sodass auch diejenigen, die nicht live teilnehmen konnten, die Diskussion nachholen können.
- None.
- None.
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that its management team will participate in the following upcoming investor conference:
Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Wednesday, September 4, 2024, at 7:45 a.m. ET
Location: Marriott Marquis in New York, NY
Format: Fireside Chat
A live webcast of the Fireside Chat will be available under the News & Events section of Olema’s investor relations website at ir.olema.com. The webcasts will be archived for at least 30 days.
About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for women living with cancer. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally-available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), currently in a Phase 3 clinical trial called OPERA-01. In addition, Olema is developing a potent KAT6 inhibitor (OP-3136). Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit us at www.olema.com.
Contact:
Geoffrey Mogilner, Investor Relations and Communications
ir@olema.com
FAQ
When is Olema Oncology participating in the Morgan Stanley Healthcare Conference?
Where can I watch the webcast of Olema Oncology's Fireside Chat?
What is the format of Olema Oncology's presentation at the Morgan Stanley conference?
How long will the webcast of Olema Oncology's presentation be archived?
What is Olema Oncology's stock symbol?
